<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39553769</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2218-6050</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Open veterinary journal</Title><ISOAbbreviation>Open Vet J</ISOAbbreviation></Journal><ArticleTitle>Selective protease inhibitors from secondary metabolites of Philippine medicinal plants against porcine epidemic diarrhea virus: A computational veterinary drug discovery approach.</ArticleTitle><Pagination><StartPage>2192</StartPage><EndPage>2214</EndPage><MedlinePgn>2192-2214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5455/OVJ.2024.v14.i9.8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Porcine epidemic diarrhea virus (PEDV) is a recurring coronavirus that causes severe diarrhea in pigs with high mortality and morbidity rates, especially in neonatal pigs. Despite the availability of vaccines, their efficacy is limited owing to antigenic differences between the vaccine and field strains, which poses a challenge to infection control. Antiviral drugs targeting conserved PEDV proteins show promise for complementing vaccination strategies. PEDV Nsp3 (PL2Pro) and Nsp5 (3CLPro) are essential proteases vital for viral replication, making them attractive targets for drug development against PEDV.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">To address the lack of therapeutics against recurring PEDV outbreaks and bridge the gap in the application of bioinformatics in veterinary drug discovery, this study aimed to discover compounds that inhibit PEDV proteases from Philippine medicinal plants by applying a modified virtual screening methodology that considers the physiology of swine hosts.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study employed a library of 690 metabolites from Philippine medicinal plants to screen for potential protease inhibitors targeting PEDV PL2Pro and 3CLPro. This includes evaluating the binding affinity, pharmacokinetics, dynamic stability, and critical binding site residues. Compounds demonstrating high affinity underwent a modified ADMET analysis, considering the enteric localization of the virus and potential toxicity to swine hosts. Furthermore, molecular dynamics simulations assessed compound stability under physiological swine conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study identified Bisandrographolide from <i>Andrographis paniculata</i>, CID 162866964 from <i>Euphorbia neriifolia</i>, and betulinic acid from <i>Vitex negundo</i> and <i>Ocimum basilicum</i> as metabolites that bind favorably and selectively to PEDV 3CLPro and have excellent pharmacokinetic properties and dynamic stability. In contrast, no selective inhibitor for PL2pro passed the same criteria.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Employing the modified virtual screening protocol tailored for swine host considerations, the compounds identified in this study are anticipated to exert inhibitory effects against PEDV without off-target binding to analogous swine proteases and receptors. CID 162866964, bisandrographolide, and betulinic acid show promise for developing potent antivirals against PEDV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Guzman</LastName><ForeName>John Christian C</ForeName><Initials>JCC</Initials><AffiliationInfo><Affiliation>Virology and Vaccine Research and Development Program, Department of Science and Technology, Industrial Technology Development Institute, Taguig, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dulay</LastName><ForeName>Albert Neil G</ForeName><Initials>ANG</Initials><AffiliationInfo><Affiliation>Virology and Vaccine Research and Development Program, Department of Science and Technology, Industrial Technology Development Institute, Taguig, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orosco</LastName><ForeName>Fredmoore L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Virology and Vaccine Research and Development Program, Department of Science and Technology, Industrial Technology Development Institute, Taguig, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>S&amp;T Fellows Program, Department of Science and Technology, Bicutan, Taguig, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, University of the Philippines- Manila, Manila, Philippines.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Libya</Country><MedlineTA>Open Vet J</MedlineTA><NlmUniqueID>101653182</NlmUniqueID><ISSNLinking>2218-6050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053485" MajorTopicYN="Y">Porcine epidemic diarrhea virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010946" MajorTopicYN="Y">Plants, Medicinal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011480" MajorTopicYN="Y">Protease Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="Y">Drug Discovery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013553" MajorTopicYN="N">Swine Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010679" MajorTopicYN="N" Type="Geographic">Philippines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064210" MajorTopicYN="N">Secondary Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral</Keyword><Keyword MajorTopicYN="N">Drug discovery</Keyword><Keyword MajorTopicYN="N">PEDV</Keyword><Keyword MajorTopicYN="N">Veterinary drug</Keyword><Keyword MajorTopicYN="N">Virtual screening</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39553769</ArticleId><ArticleId IdType="pmc">PMC11563624</ArticleId><ArticleId IdType="doi">10.5455/OVJ.2024.v14.i9.8</ArticleId><ArticleId IdType="pii">OVJ-14-2192</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abraham M.J., Murtola T., Schulz R., Páll S., Smith J.C., Hess B., Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25.</Citation></Reference><Reference><Citation>Anderson A.C. The process of structure-based drug design. Chem. Biol. 2003;10:787–797.</Citation><ArticleIdList><ArticleId IdType="pubmed">14522049</ArticleId></ArticleIdList></Reference><Reference><Citation>Batool M., Ahmad B., Choi S. A structure-based drug discovery paradigm. Int. J. Mol. Sci. 2019;20:2783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601033</ArticleId><ArticleId IdType="pubmed">31174387</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 2000;28:235–242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>Best R.B., Zhu X., Shim J., Lopes P.E.M., Mittal J., Feig M., Jr MacKerell A.D. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone ϕ, ψ and side-chain χ1 and χ2 Dihedral angles. J. Chem. Theory Comput. 2012;8:3257–3273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549273</ArticleId><ArticleId IdType="pubmed">23341755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng T., Li Q., Zhou Z., Wang Y., Bryant S.H. Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J. 2012;14:133–141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3282008</ArticleId><ArticleId IdType="pubmed">22281989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H.F., Chen C.C., Moses D.C., Chen Y.H., Lin C.H., Tsai Y.C., Chou C.Y. Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine. Antiviral Res. 2018;158:199–205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113753</ArticleId><ArticleId IdType="pubmed">30138642</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5335600</ArticleId><ArticleId IdType="pubmed">28256516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayrit F., Guidote A., Gloriani N., de Paz-Silava S.L., Villaseñor I., Macahig R.A., Tan M., Chua J.R., Sia I. Philippine medicinal plants with potential immunomodulatory and anti-SARS-CoV-2 activities. Philipp. J. Sci. 2021;150:999–1015.</Citation></Reference><Reference><Citation>DiMasi J.A., Grabowski H.G., Hansen R.W. Innovation in the pharmaceutical industry: new estimates of RandD costs. J. Health Econ. 2016;47:20–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Liu X., Zhang J.Z.H. Interaction entropy: a new paradigm for highly efficient and reliable computation of protein–ligand binding free energy. J. Am. Chem. Soc. 2016;138:5722–5728.</Citation><ArticleIdList><ArticleId IdType="pubmed">27058988</ArticleId></ArticleIdList></Reference><Reference><Citation>Forli S., Huey R., Pique M.E., Sanner M., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905–919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868550</ArticleId><ArticleId IdType="pubmed">27077332</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan L., Yang H., Cai Y., Sun L., Di P., Li W., Liu G., Tang Y. ADMET-score—a comprehensive scoring function for evaluation of chemical drug-likeness. Med. Chem. Comm. 2018;10:148–157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350845</ArticleId><ArticleId IdType="pubmed">30774861</ArticleId></ArticleIdList></Reference><Reference><Citation>Halgren T.A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996;17:616–641.</Citation></Reference><Reference><Citation>Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminformatics. 2012;4:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3542060</ArticleId><ArticleId IdType="pubmed">22889332</ArticleId></ArticleIdList></Reference><Reference><Citation>Henze L.J., Koehl N.J., O’Shea J.P., Kostewicz E.S., Holm R., Griffin B.T. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review. J. Pharm. Pharmacol. 2019;71:581–602.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635685</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevener K.E., Zhao W., Ball D.M., Babaoglu K., Qi J., White S.W., Lee R.E. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J. Chem. Inf. Model. 2009;49:444–460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2788795</ArticleId><ArticleId IdType="pubmed">19434845</ArticleId></ArticleIdList></Reference><Reference><Citation>Khursheed A., Jain V., Wani A.R. Euphorbia hirta as a gold mine of high-value phytochemicals: a comprehensive review of its pharmacological activities and possible role against SARS-CoV-2. Biomed. Res. Ther. 2022;9:4930–4949.</Citation></Reference><Reference><Citation>Kim J.M., Pathak R.K. Editorial: vetinformatics: an insight for decoding livestock systems through in silico biology. Front. Vet. Sci. 2023;10:1292733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10643129</ArticleId><ArticleId IdType="pubmed">38026650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam T.P., Nguyen D.N., Mai T.T., Tran T.D., Le M.T., Huynh P.N.H., Nguyen D.T., Tran V.H., Trinh D.T.T., Truong P., Vo C.V.T., Thai K.M. Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches. Struct. Chem. 2022;33:1707–1725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9253262</ArticleId><ArticleId IdType="pubmed">35811783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus. Virol. J. 2015;12:193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687282</ArticleId><ArticleId IdType="pubmed">26689811</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Zhu L., Wang L., Huang Y., Zhang Y., Zhao D., Wang L., Yi D., Hou Y., Wu T. Identification of two flavonoids antiviral inhibitors targeting 3C-like protease of porcine epidemic diarrhea virus. Front. Microbiol. 2024;15:1357470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10987960</ArticleId><ArticleId IdType="pubmed">38572230</ArticleId></ArticleIdList></Reference><Reference><Citation>Macalalad M.A.B., Orosco F.L. In silico identification of multi-target inhibitors from medicinal fungal metabolites against the base excision repair pathway proteins of African swine fever virus. RSC Adv. 2024;14:10039–10055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10964135</ArticleId><ArticleId IdType="pubmed">38533097</ArticleId></ArticleIdList></Reference><Reference><Citation>Masyita A., Mustika Sari R., Dwi Astuti A., Yasir B., Rahma Rumata N., Emran T.B., Nainu F., Simal-Gandara J. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem. X. 2022;13:100217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9039924</ArticleId><ArticleId IdType="pubmed">35498985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri A., Bertola M. Alvascience: a new software suite for the QSAR workflow applied to the blood–brain barrier permeability. Int. J. Mol. Sci. 2022;23:12882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9655980</ArticleId><ArticleId IdType="pubmed">36361669</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785–2791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760638</ArticleId><ArticleId IdType="pubmed">19399780</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open babel: an open chemical toolbox. J. Cheminformatics. 2011;3:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle N.M., Sayle R.A. Comparing structural fingerprints using a literature-based similarity benchmark. J. Cheminf. 2016;8:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932683</ArticleId><ArticleId IdType="pubmed">27382417</ArticleId></ArticleIdList></Reference><Reference><Citation>Orosco F.L. Current advances in antiviral potential of artemisia against major viral infections. J. Bacteriol. Virol. 2023;53:61–73.</Citation></Reference><Reference><Citation>Orosco F., Quimque M. Antiviral potential of terpenoids against major viral infections: recent advances, challenges, and opportunities. J. Adv. Biotechnol. Exp. Ther. 2024;7:221.</Citation></Reference><Reference><Citation>Orosco F.L., Wong J.E. Andrographolides as antiviral agents: insights into mechanisms, modifications, and delivery innovations. Trop. J. Nat. Prod. Res. 2023;7:5341–5354.</Citation></Reference><Reference><Citation>Paraguison-Alili R., Domingo C.Y.J. Phylogenetic tracking of current porcine epidemic diarrhea virus (PEDV) strains in the Philippines. Arch. Virol. 2016;161:2601–2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087094</ArticleId><ArticleId IdType="pubmed">27350060</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak R.K., Kim J.M. Vetinformatics from functional genomics to drug discovery: insights into decoding complex molecular mechanisms of livestock systems in veterinary science. Front. Vet. Sci. 2022;9:1008728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9691653</ArticleId><ArticleId IdType="pubmed">36439342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak R.K., Kim W.I., Kim J.M. Targeting the PEDV 3CL protease for identification of small molecule inhibitors: an insight from virtual screening ADMET prediction, molecular dynamics, free energy landscape, and binding energy calculations. J. Biol. Eng. 2023;17:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112315</ArticleId><ArticleId IdType="pubmed">37072787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak R.K., Kim D.Y., Lim B., Kim J.M. Investigating multi-target antiviral compounds by screening of phytochemicals from neem (Azadirachta indica) against PRRSV: a vetinformatics approach. Front. Vet. Sci. 2022a;9:854528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244183</ArticleId><ArticleId IdType="pubmed">35782555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak R.K., Seo Y.J., Kim J.M. Structural insights into inhibition of PRRSV Nsp4 revealed by structure-based virtual screening, molecular dynamics, and MM-PBSA studies. J. Biol. Eng. 2022b;16:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864930</ArticleId><ArticleId IdType="pubmed">35193698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612.</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Saidu M.B., Kúsz N., Tsai Y.C., Vágvölgyi M., Berkecz R., Kókai D., Burián K., Hohmann J., Rédei D. Triterpenes and phenolic compounds from Euphorbia deightonii with antiviral activity against herpes simplex virus type-2. Plants. 2022;11:764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8955370</ArticleId><ArticleId IdType="pubmed">35336645</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamat S.E.A., Collantes T.M.A., Lumbera W.M.L., Tablizo F.A., Mutia C.T.M., Ong J.D.P., Bandoy D.J.D.R. Sequence analysis of new variants of porcine epidemic diarrhea virus in Luzon, Philippines, in 2017. Arch. Virol. 2021;166:1859–1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055054</ArticleId><ArticleId IdType="pubmed">33876315</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwede T., Kopp J., Guex N., Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003;31:3381–3385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC168927</ArticleId><ArticleId IdType="pubmed">12824332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapovalov M.V., Dunbrack R.L. A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Struct. Lond. Engl. 2011;19:844–858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3118414</ArticleId><ArticleId IdType="pubmed">21645855</ArticleId></ArticleIdList></Reference><Reference><Citation>Štekláč M., Zajaček D., Bučinský L. 3CLpro and PLpro affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found? J. Mol. Struct. 2021;1245:130968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238401</ArticleId><ArticleId IdType="pubmed">34219808</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.C., Tsai C.C., Mehboob S., Hevener K.E., Johnson M.E. Comparison of radii sets, entropy QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI) J. Comput. Chem. 2015;36:1859–1873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4688044</ArticleId><ArticleId IdType="pubmed">26216222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sujatha P.L, Kumarasamy P, Preetha S.P., Balachandran P. Vetinformatics: a new paradigm for quality veterinary services. Res. Rev. J. Vet. Sci. Technol. 2018;5:16–19.</Citation></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdés-Tresanco M.S., Valdés-Tresanco M.E., Valiente P.A., Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 2021;17:6281–6291.</Citation><ArticleIdList><ArticleId IdType="pubmed">34586825</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanommeslaeghe K., Hatcher E., Acharya C., Kundu S., Zhong S., Shim J., Darian E., Guvench O., Lopes P., Vorobyov I., MacKerell A.D. CHARMM general force field (CGenFF): a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 2010;31:671–690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2888302</ArticleId><ArticleId IdType="pubmed">19575467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergoten G., Bailly C. In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CLpro) and SARS-CoV-2 (Mpro) Silico Pharmacol. 2021;9:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248761</ArticleId><ArticleId IdType="pubmed">34230874</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma D., Mitra D., Paul M., Chaudhary P., Kamboj A., Thatoi H., Janmeda P., Jain D., Panneerselvam P., Shrivastav R., Pant K., Das Mohapatra P.K. Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components. Curr. Res. Pharmacol. Drug Discov. 2021;2:100038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178537</ArticleId><ArticleId IdType="pubmed">34870149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157–1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Zhu W. Molecular docking for drug discovery and development: a widely used approach but far from perfect. Future Med. Chem. 2016;8:1707–1710.</Citation><ArticleIdList><ArticleId IdType="pubmed">27578269</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetzel S., Klein K., Renner S., Rauh D., Oprea T.I., Mutzel P., Waldmann H. Interactive exploration of chemical space with Scaffold Hunter. Nat. Chem. Biol. 2009;5(8):581–583.</Citation><ArticleIdList><ArticleId IdType="pubmed">19561620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong F., Krishnan A., Zheng E.J., Stärk H., Manson A.L., Earl A.M., Jaakkola T., Collins J.J. Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery. Mol. Syst. Biol. 2022;18:e11081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9446081</ArticleId><ArticleId IdType="pubmed">36065847</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong G., Wu Z., Yi J., Fu L., Yang Z., Hsieh C., Yin M., Zeng X., Wu C., Lu A., Chen X., Hou T., Cao D. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49:W5–W14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262709</ArticleId><ArticleId IdType="pubmed">33893803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye G., Deng F., Shen Z., Luo R., Zhao L., Xiao S., Fu Z.F., Peng G. Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease. Virology. 2016;494:225–235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111274</ArticleId><ArticleId IdType="pubmed">27128350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Zhou J., Wang X., Ma L., Li J., Yang L., Yuan H., Pang D., Ouyang H. Porcine epidemic diarrhea virus: an updated overview of virus epidemiology, virulence variation patterns and virus–host interactions. Viruses. 2022;14:2434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9695474</ArticleId><ArticleId IdType="pubmed">36366532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen H., Zou M., Oerlemans R., Shao C., Ren Y., Zhang R., Huang X., Li G., Cong Y. Hypericin inhibit alpha-coronavirus replication by targeting 3CL protease. Viruses. 2021;13:1825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8473218</ArticleId><ArticleId IdType="pubmed">34578406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>